APA (7th ed.) Citation

S, K., B, M., JR, Y., WY, P., & S, M. (2023). Exploring the utility of FTS as a bonafide binding partner for EGFR: A potential drug target for cervical cancer. Computers in biology and medicine, 167, 107592. https://doi.org/10.1016/j.compbiomed.2023.107592

Chicago Style (17th ed.) Citation

S, Krishnamoorthy, Muruganantham B, Yu JR, Park WY, and Muthusami S. "Exploring the Utility of FTS as a Bonafide Binding Partner for EGFR: A Potential Drug Target for Cervical Cancer." Computers in Biology and Medicine 167 (2023): 107592. https://doi.org/10.1016/j.compbiomed.2023.107592.

MLA (9th ed.) Citation

S, Krishnamoorthy, et al. "Exploring the Utility of FTS as a Bonafide Binding Partner for EGFR: A Potential Drug Target for Cervical Cancer." Computers in Biology and Medicine, vol. 167, 2023, p. 107592, https://doi.org/10.1016/j.compbiomed.2023.107592.